CYH vs SGRY

For growth investors, Surgery Partners, Inc.

(SGRY) is the stronger pick with 6. 2% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Surgery Partners, Inc. (SGRY) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Surgery Partners, Inc.

(SGRY) delivered a total return of -71. 9%, compared to -79. 5% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: SGRY returned +4. 9% versus CYH's -80. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Surgery Partners, Inc.

(SGRY) is the lower-risk stock at 1. 04β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 53% more volatile than SGRY relative to the S&P 500.

By revenue growth (latest reported year), Surgery Partners, Inc.

(SGRY) is pulling ahead at 6. 2% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to 54. 1% for Surgery Partners, Inc.. Over a 3-year CAGR, SGRY leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Community Health Systems, Inc.

(CYH) is the more profitable company, earning 4. 1% net margin versus -2. 4% for Surgery Partners, Inc. — meaning it keeps 4. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus -79. 4% for CYH. At the gross margin level — before operating expenses — SGRY leads at 23. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SGRY: 27.

5% to $18. 60.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Surgery Partners, Inc.

(SGRY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 04)). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SGRY: +4. 9%, CYH: -80. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CYH is a small-cap deep-value stock; SGRY is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.